Mealey's (July 1, 2019, 12:59 PM EDT) -- BOSTON — A federal district court did not err in dismissing lead plaintiffs’ claims in a securities class action against a biopharmaceutical company and three of its current or former executive officers because the plaintiffs failed to sufficiently plead scienter in making their federal securities law claims, a First Circuit U.S. Court of Appeals panel ruled June 27 (Metzler Asset Management GmbH, et al. v. Kingsley, et al., Nos. 18-1369 and 18-1472, 1st Cir., 2019 U.S. App. LEXIS 19237)....